PharmGen Science Inc (004720) — Long-term Investment Intensity

Latest as of September 2019: 28.8%

PharmGen Science Inc (004720) has a Long-term Investment Intensity of 28.8% as of September 2019. Long-term investments of ₩28.69 Billion represent 28.8% of total assets of ₩99.75 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check 004720 financial resilience to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

28.8%
LT Investments / Total Assets

Long-term Investments

₩28.69 Billion
KRW

Total Assets

₩99.75 Billion
KRW

Country

Korea
KO

PharmGen Science Inc Long-term Investment Intensity (2013–2018)

This chart shows how PharmGen Science Inc's Long-term Investment Intensity has evolved across 6 annual periods from 2013 to 2018. As of September 2019, the intensity stands at 28.8%, reflecting long-term investments of ₩28.69 Billion against total assets of ₩99.75 Billion KRW. For the complete balance sheet picture, see PharmGen Science Inc assets under control.

Annual Long-term Investment Intensity for PharmGen Science Inc (2013–2018)

The table below presents the year-by-year Long-term Investment Intensity for PharmGen Science Inc from 2013 to 2018, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read PharmGen Science Inc (004720) total liabilities for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (KRW) Total Assets Change (pp)
2018 3.7% ₩3.60 Billion ₩98.19 Billion ▼ -0.1 pp
2017 3.7% ₩2.54 Billion ₩68.48 Billion ▲ +1.7 pp
2016 2.0% ₩1.32 Billion ₩64.30 Billion ▼ -0.1 pp
2015 2.1% ₩997.34 Million ₩46.45 Billion ▲ +0.5 pp
2014 1.7% ₩703.54 Million ₩42.04 Billion ▲ +0.3 pp
2013 1.3% ₩526.33 Million ₩39.33 Billion
pp = percentage points